A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma have?
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma has 136 citations in the OpenAlex counts ScholarIQ stores.
When was A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma published?
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma has 2015 year in the ScholarIQ index.
What is the open-access status of A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma?
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma?
The DOI for A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma is on the source record.
What is the PMID of A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma?
The PMID for A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma is on the source record.
What is the OpenAlex record for A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma?
The OpenAlex for A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma is on the source record.